Browsing by Author "Mujuru, Hilda A."
Now showing 1 - 1 of 1
Results Per Page
Sort Options
Item Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial(The Lancet HIV, 2022-09-17) Amuge, Pauline; Lugemwa, Abbas; Mujuru, Hilda A.; Kityo, Cissy M.; Atwine, Lorna; Ford, DeborahYoung children living with HIV have few treatment options. We aimed to assess the efficacy and safety of dolutegravir-based antiretroviral therapy (ART) in children weighing between 3 kg and less than 14 kg.